|
|
Volumn 12 Suppl 1, Issue , 2010, Pages
|
|
Type I interferon in organ-targeted autoimmune and inflammatory diseases.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BETA INTERFERON;
ANIMAL;
AUTOIMMUNE DISEASE;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
HUMAN;
IMMUNOLOGY;
INSULIN DEPENDENT DIABETES MELLITUS;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
MOUSE;
MULTIPLE SCLEROSIS;
REVIEW;
RHEUMATOID ARTHRITIS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TREATMENT OUTCOME;
ANIMALS;
ARTHRITIS, RHEUMATOID;
AUTOIMMUNE DISEASES;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 1;
DISEASE MODELS, ANIMAL;
HUMANS;
INTERFERON-ALPHA;
INTERFERON-BETA;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MICE;
MOLECULAR TARGETED THERAPY;
MULTIPLE SCLEROSIS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 79955694610
PISSN: None
EISSN: 14786362
Source Type: Journal
DOI: 10.1186/ar2886 Document Type: Review |
|
Times cited : (111)
|
|
References (0)
|
